How do Memo Genesis doses compare to recommended dietary intakes for each ingredient?
This fact-check may be outdated. Consider refreshing it to get the most current information.
Executive summary
Memo Genesis is marketed as a once-daily brain-health capsule, but publicly available reporting does not publish a transparent, complete ingredient-by-ingredient label with per‑dose milligram amounts, so a direct side‑by‑side comparison to established Recommended Dietary Intakes (RDIs) is not possible from these sources [1] [2]. Independent signals allow only partial comparisons: one clinical product named “Memo®” used one capsule daily containing 750 mg lyophilized royal jelly in a short trial [3] [4], and industry writeups reference other single ingredients like Memo‑Q at 400–600 mg/day, but none of the sources provide a complete, validated Memo Genesis ingredient list with amounts to compare to RDIs [5] [1].
1. What the available product pages actually say about dosing
Memo Genesis is consistently presented as a single‑capsule‑per‑day supplement in marketing and reseller pages recommending "take one capsule in the morning" [2] [1]. The company‑style copy and third‑party reseller pages emphasize once‑daily dosing but do not publish a full supplement facts panel with per‑ingredient weights in the cited materials, so the only firm dosing claim across sources is daily one‑capsule usage rather than per‑ingredient milligram values [2] [1].
2. What clinical trials we can compare — and their limits
A distinct product labeled Memo® (not explicitly the same commercial Memo Genesis formulation) was studied in a randomized trial where subjects took one capsule daily for four weeks; that product contained 750 mg of lyophilized royal jelly plus standardized botanical extracts, and the trial reported a statistically superior MMSE change versus placebo [3] [4]. That single‑capsule, 750 mg royal jelly dose can be compared to the absence of official RDIs for royal jelly—royal jelly and many botanical extracts lack established RDIs, so clinical dosing is usually guided by trial data and safety literature rather than government numeric RDIs [3] [4].
3. Ingredients that do have comparators — what the reporting shows
Some ingredients often used in brain supplements, cited in the broader reporting, have general recommended ranges in published literature: Memo‑Q (a silk‑protein ingredient) is discussed in industry materials with effective doses of roughly 200–600 mg/day and commonly cited clinical benefits around 400–600 mg/day [5]. Vitamin B12 was flagged in an analysis of a related product (Memo Surge) as present at extremely high percent Daily Values in that product, but that analysis is product‑specific and not Memo Genesis; it illustrates how some brain supplements do include micronutrients with established RDIs while others center on botanicals that do not [6]. The reporting does not show Memo Genesis per‑ingredient milligrams for any vitamins or minerals that could be compared to official RDIs [1] [2].
4. Advertising, ambiguity and risk: why transparency matters
Marketing narratives for Memo Genesis lean on “scientifically formulated” language and industry trend pieces, yet press releases and reseller pages do not supply a full supplement facts panel for independent verification [7] [1] [2]. Investigative and consumer‑protection coverage warns that social‑media advertising for some memory supplements can use exaggerated claims, fake endorsements, and omit ingredient specifics—an industry dynamic that increases the importance of seeing per‑serving quantities to compare to RDIs or clinical dosing [8]. Without a verified label, one cannot responsibly assert whether Memo Genesis provides sub‑RDI, RDI‑level, therapeutic, or supra‑physiologic doses of any specific vitamin, mineral, or botanical.
5. Practical conclusion and next steps for comparison
Based on the cited reporting, a responsible, evidence‑based comparison cannot be completed because Memo Genesis’s detailed per‑ingredient dosing is not provided in these sources; the only consistent dosing claim is one capsule daily [2] [1]. Where individual ingredients are discussed elsewhere (royal jelly at 750 mg in a product called Memo®, Memo‑Q at 400–600 mg in industry pieces), those specific values are not shown as Memo Genesis ingredients and therefore cannot be directly mapped to official RDIs from these sources [3] [4] [5]. The necessary next steps are transparent: obtain the product’s Supplement Facts panel or independent lab analysis, then compare each listed nutrient’s milligrams/micrograms to authoritative RDIs (FDA, EFSA, or national agencies) or to clinical trial dosing for botanicals and novel ingredients.